Biotech news
Americas
Fresenius Kabi is facing a lawsuit by two Pharmasphere subsidiaries over claims that it infringed a patent covering a treatment for hypocalcemia, a condition where the blood sugar level is lower than normal. 7 December 2021
Americas
Moderna has failed to reverse an unfavourable ruling related to its COVID-19 vaccine technology, after the US Court of Appeals for the Federal Circuit upheld the validity of a patent owned by Arbutus Biopharma. 2 December 2021
Biotech
Medical and human rights groups have called on US President Joe Biden to step up his personal engagement and help put in place a temporary waiver of IP rights for COVID-19 vaccines. 23 November 2021
Pharma
The English High Court has found that a challenged claim of Bayer's targeted cancer drug sorafenib is invalid due to obviousness, in a win for Israeli pharmaceutical company Teva Pharmaceuticals. 11 October 2021
Biotech
Medical device company SurgiSil has persuaded the US Court of Appeals for the Federal Circuit that its application for a design patent covering a lip filler was erroneously rejected by the US Patent and Trademark Office. 6 October 2021
Biotech
Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry. 28 September 2021
Asia
Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh. 9 September 2021
Biotech
The US District Court for the Northern District of Illinois has refused to dismiss a lawsuit from AbbVie which alleges Icelandic pharmaceutical company Alvotech infringed patents related to its arthritis drug Humira. 26 August 2021
Biotech
Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products. 29 July 2021
Biotech
A California jury has ordered Novartis to pay $178 million to rival drugmaker Daiichi Sankyo for willfully infringing two cancer drug patents. 26 July 2021